Bayer Set to Continue Stepping Up External Collaborations to Develop New Drugs: Regional BD Chief

November 30, 2023
Friedemann Janus, SVP, Head of Regional Business Development & Licensing, Open Innovation and Divestitures With as much as 60% of its pipeline coming from external collaborations of some form, Bayer expects this ratio to rise even further as it continues...read more